The eosinophilia myalgia syndrome (EMS) is an inflammatory multisystem disease which emerged in epidemic form in 1989 and was linked to the ingestion of L-tryptophan. ' In the acute form of the EMS, severe myalgia and pronounced blood eosinophilia are accompanied by widespread organ involvement with the skin, lungs, serosal membranes, and the peripheral nervous system being involved most frequently.2 3 The chronic form of the EMS is characterised by progressive fascial and cutaneous fibrosis, leading to a clinical picture resembling eosinophilic fasciitis, accompanied by polyneuropathy, chronic fatigue, and psychological dysfunction.3 I A spectrum of vascular lesions has been described including perivascular aggregation of mononuclear cells, intimal and medial thickening and fibrosis, ultrastructural alterations of the vascular endothelium, and frank vasculitis with mural infiltration by mononuclear cells.2 5 6 The last of these was found primarily in small arteries, veins and capillaries, and by immunofluorescence microscopy no deposition of immunoglobulins or complement components was found.2 5 6 These histopathological features resemble those of the pauci-immune small vessel vasculitides, a group of diseases strongly associated with antineutrophil cytoplasmic antibodies (ANCA).7 In the March 1991 issue of this joumal Cilursu and colleagues8 reported a patient with acute EMS and perinuclear ANCA (pANCA) with antimyeloperoxidase (MPO) specificity together with a small vessel vasculitis in skeletal muscle. This report prompted the question whether EMS also is an ANCA associated disease.
From a nationwide collection of EMS sera, we tested a random sample of 45 sera for ANCA. The sera were from 39 females (age 30-69 years) and six males (age 51-61 years) who fulfilled the diagnostic criteria of chronic EMS. 4 
